Zenas Biopharma, Common Etf Price on December 4, 2024
| ZBIO Etf | USD 8.92 0.33 3.57% |
If you're considering investing in Zenas Etf, it is important to understand the factors that can impact its price. As of today, the current price of Zenas BioPharma, stands at 8.92, as last reported on the 13th of December 2024, with the highest price reaching 8.97 and the lowest price hitting 8.92 during the day. Zenas BioPharma, Common shows Sharpe Ratio of -0.15, which attests that the etf had a -0.15% return per unit of risk over the last 3 months. Zenas BioPharma, Common exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Zenas BioPharma,'s Standard Deviation of 5.87, mean deviation of 4.32, and Market Risk Adjusted Performance of (3.23) to validate the risk estimate we provide.
Zenas Etf price history is provided at the adjusted basis, taking into account all of the recent filings.
Zenas |
Sharpe Ratio = -0.1546
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ZBIO |
Estimated Market Risk
| 5.87 actual daily | 52 52% of assets are less volatile |
Expected Return
| -0.91 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.15 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Zenas BioPharma, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Zenas BioPharma, by adding Zenas BioPharma, to a well-diversified portfolio.
Zenas BioPharma, Main Headline on 4th of December 2024
Acquisition by Moulder Leon O Jr of 45000 shares of Zenas Bi... by Moulder Leon O Jr
Filed transaction by Zenas BioPharma, Common Director, Officer: Chief Executive Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Zenas BioPharma, Valuation on December 4, 2024
It is possible to determine the worth of Zenas BioPharma, on a given historical date. On December 4, 2024 Zenas was worth 10.63 at the beginning of the trading date compared to the closed value of 9.84. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Zenas BioPharma, etf. Still, in general, we apply an absolute valuation method to find Zenas BioPharma,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Zenas BioPharma, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Zenas BioPharma,'s related companies.
| Open | High | Low | Close | Volume | |
| 11.11 | 11.21 | 10.56 | 10.73 | 286,200 | |
12/04/2024 | 10.63 | 10.63 | 9.80 | 9.84 | 383,800 |
| 10.75 | 10.93 | 10.35 | 10.50 | 428,227 |
| Backtest Zenas BioPharma, | | | Zenas BioPharma, History | | | Zenas BioPharma, Valuation | Previous | Next |
Zenas BioPharma, Trading Date Momentum on December 4, 2024
| On December 05 2024 Zenas BioPharma, Common was traded for 10.50 at the closing time. The top price for the day was 10.93 and the lowest listed price was 10.35 . The trading volume for the day was 428.2 K. The trading history from December 5, 2024 was a factor to the next trading day price boost. The trading date delta against the next closing price was 6.71% . The trading date delta against the current closing price is 6.00% . |
Zenas BioPharma, Common Fundamentals Correlations and Trends
By evaluating Zenas BioPharma,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Zenas BioPharma,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Zenas financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Zenas BioPharma, Etf history
Zenas BioPharma, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Zenas is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Zenas BioPharma, Common will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Zenas BioPharma, stock prices may prove useful in developing a viable investing in Zenas BioPharma,
The investment seeks daily investment results, before fees and expenses, that correspond to three times the inverse of the daily performance of the NASDAQ Biotechnology Index. ProShares UltraPro is traded on NGM Exchange in the United States.
Zenas BioPharma, Quarterly Net Working Capital |
|
Zenas BioPharma, Etf Technical Analysis
Zenas BioPharma, technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
Price Boundaries
Zenas BioPharma, Period Price Range
Low | December 13, 2024
| High |
0.00 | 0.00 |
Zenas BioPharma, Common cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Zenas BioPharma, December 13, 2024 Market Strength
Market strength indicators help investors to evaluate how Zenas BioPharma, etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Zenas BioPharma, shares will generate the highest return on investment. By undertsting and applying Zenas BioPharma, etf market strength indicators, traders can identify Zenas BioPharma, Common entry and exit signals to maximize returns
Zenas BioPharma, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Zenas BioPharma,'s price direction in advance. Along with the technical and fundamental analysis of Zenas Etf historical price patterns, it is also worthwhile for investors to track various predictive indicators of Zenas to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.1) | |||
| Jensen Alpha | (0.91) | |||
| Total Risk Alpha | (1.71) | |||
| Treynor Ratio | (3.24) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Other Information on Investing in Zenas Etf
Zenas BioPharma, financial ratios help investors to determine whether Zenas Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zenas with respect to the benefits of owning Zenas BioPharma, security.